Molecules 2020, 25, 3793
8 of 10
Methyl hydrogen 1-(4-trifluoromethylphenyl)-1-hydroxymethylphosphonate (2e). 13C NMR (DMSO-d6)
δ:
53.1 (d, 2JP,C = 6.5, OCH3), 69.7 (d, 1JP,C = 157.9, PCH), 124.7–125.0 (m, C3), 124.9 (q, 1JF,C = 271.1, CF3),
127.3–128.7 (m, C2, C4), 145.0 (C1); 1H NMR (DMSO-d6)
δ
: 3.56 (d, 3J = 10.3, 3H, OMe), 4.96 (d, 2J =
14.6, 1H, PCH), 7.57–7.72 (m, 4H, Ar).
Methyl hydrogen 1-(4-methylphenyl)-1-hydroxymethylphosphonate (2f). 13C NMR (DMSO-d6)
δ
: 21.2
(Ar-CH3), 52.8 (d, 2JP,C = 6.6, OCH3), 70.0 (d, 1JP,C = 160.2, PCH), 127.7 (d, 3J = 5.6, C2), 128.7 (d, 4J =
2.1, C3), 136.5 (d, 5J = 3.1, C4), 136.9 (C1); 1H NMR (DMSO-d6)
δ
: 2.28 (s, 3H, Ar-CH3), 3.52 (d, 3J = 10.2,
3H, OMe), 4.76 (d, 2J = 13.0, 1H, PCH), 7.06–7.38 (m, 4H, Ar).
Ethyl hydrogen 1-(4-nitrophenyl)-1-hydroxymethylphosphonate (2h
5.6, CH3), 62.0 (d, 2J = 6.5, OCH2), 69.1 (d, 1J = 157.5, PCH), 122.7 (d, 4J = 2.4, C3), 128.2 (d, 3J = 4.9, C2),
146.5 (d, 5J = 3.6, C4), 147.6 (C1); 1H NMR (DMSO-d6) : 1.17 (t, 3JH,H = 7.0, 3H, CH3), 3.91 (dq, 3JP,H
8.1, 3JH,H = 7.0, 2H, OCH2), 5.03 (d, 2J = 15.7, 1H, PCH), 7.65–7.72 (m, 2H, H2), 8.16–8.23 (m, 2H, H3).
Ethyl hydrogen 1-(4-chlorophenyl)-1-hydroxymethylphosphonate (2i). 13C NMR (DMSO-d6) : 16.6 (d, 3J =
5.5, CH3), 61.7 (d, 2J = 6.5, OCH2), 69.3 (d, 1J = 160.7, PCH), 127.7 (d, 4J = 1.9, C3), 129.2 (d, 3J = 5.3, C2),
131.8 (d, 5J = 3.7, C4), 138.6 (C1); 1H NMR (DMSO-d6) : 1.15 (t, 3JH,H = 7.1, 3H, CH3), 3.91 (dq, 3JP,H
7.1, 3JH,H = 7.1, 2H, OCH2), 4.84 (d, 2J = 13.8, 1H, PCH), 7.33–7.47 (m, 4H, Ar).
)
13C NMR (DMSO-d6) : 16.9 (d, 3J =
δ
δ
=
δ
δ
=
Ethyl hydrogen 1-(4-fluorophenyl)-1-hydroxymethylphosphonate (2j). 13C NMR (DMSO-d6) δ: 16.9 (d, 3J =
5.6, CH3), 61.9 (d, 2J = 6.5, OCH2), 69.5 (d, 1JP,C = 161.7, PCH), 114.8 (dd, 2JF,C = 21.1, 4JP,C = 2.0, C3),
129.7 (dd, 3JF,C = 8.2, 3JP,C = 5.5, C2), 136.1 (d, 4JF,C = 2.8), 161.9 (dd, 1JF,C = 242.4, 5JP,C = 3.2, C4); 1H
NMR (DMSO-d6) δ
: 1.15 (t, 3JH,H = 7.0, 3H, CH3), 3.87–3.95 (m, 2H, OCH2), 4.82 (d, 2J = 13.3, 1H, PCH),
7.11–7.17 (m, 2H, H3), 7.42–7.47 (m, 2H, H2).
1-(4-Trifluoromethylphenyl)-1-hydroxymethylphosphonic acid (3e). 13C NMR (DMSO-d6) : 70.5 (d, 1JP,C
δ =
157.7, PCH), 124.7–125.0 (m, C3), 124.9 (q, 1JF,C = 272.3, CF3), 127.2–128.6 (m, C4), 128.4 (d, 3JP,C = 5.0,
C2), 145.6 (C1); 1H NMR (DMSO-d6) δ: 4.80 (d, 2J = 15.0, 1H, PCH), 7.55–7.72 (m, 4H, Ar).
4. Conclusions
Kinetic study of the two-step acidic hydrolysis of a series of dialkyl α-hydroxybenzylphosphonates
and a few related model compounds allowed the mapping of the reactivity of the different substrates.
The two-step hydrolyses were characterized by k1 and k2 pseudo-first-order rate constants belonging
to the formation of the corresponding monoester monoacids and the phosphonic acids, respectively.
Electron-withdrawing substituents increased the rate, while electron-releasing ones slowed down the
hydrolyses starting with the nucleophilic attack of the water molecule. It turned out that the fission of
the second P-O-C unit is the rate-determining step. The intermediate ester–acid species were identified
and characterized.
Supplementary Materials: The following are available online: Figure S1: Concentration profile for the
components during the hydrolysis of dimethyl
α-hydroxy-4-nitrobenzylphosphonate (1b) under optimum
conditions. The R2 measure of goodness of fit is 0.989. Figure S2: Concentration profile for the components
during the hydrolysis of dimethyl -hydroxy-4-chlorobenzylphosphonate (1c) under optimum conditions.
The R2 measure of goodness of fit is 0.987. Figure S3: Concentration profile for the components
during the hydrolysis of dimethyl -hydroxy-4-fluorobenzylphosphonate (1d) under optimum conditions.
The R2 measure of goodness of fit is 0.965. Figure S4: Concentration profile for the components during
the hydrolysis of dimethyl -hydroxy-4-trifluoromethylbenzylphosphonate (1e) under optimum conditions.
The R2 measure of goodness of fit is 0.988. Figure S5: Concentration profile for the components during
the hydrolysis of dimethyl
-hydroxy-4-methylbenzylphosphonate (1f) under optimum conditions. The R2
measure of goodness of fit is 0.962. Figure S6: Concentration profile for the components during the
hydrolysis of diethyl
-hydroxy-4-nitrobenzylphosphonate (1h) under optimum conditions. The R2 measure
of goodness of fit is 0.992. Figure S7: Concentration profile for the components during the hydrolysis of
diethyl
-hydroxy-4-chlorobenzylphosphonate (1i) under optimum conditions. The R2 measure of goodness
of fit is 0.992. Figure S8: Concentration profile for the components during the hydrolysis of diethyl
-hydroxy-4-fluorobenzylphosphonate (1j) under optimum conditions. The R2 measure of goodness of fit is 0.970.
Figure S9: Concentration profile for the components during the hydrolysis of diethyl -phenylethylphosphonate
4l) under optimum conditions. The R2 measure of goodness of fit is 0.940. Figure S10: Concentration profile for the
α
α
α
α
α
α
α
α
(